Isotis Orthobiologics Inc., a developer of bone graft substitutes, is adding more workers and space in Irvine.
The company plans to hire up to 40 workers and has leased 43,538 square feet of industrial space next to its current office at 2-A Goodyear in the Irvine Spectrum.
“The demand for our product is really picking up, and we need to expand capacity,” said Pieter Wolters, Isotis’ chief executive.
Orthopedic and spinal surgeons are the primary buyers of the company’s natural and synthetic substitutes for bone grafts. The products can be used for spinal fusion, trauma repair, joint revision and surgery for head and face fractures.
Surgeons typically take bone from a patient’s hip or other area to implant near an injured site. The implanted bone contains natural proteins that help new bone form in the injured area.
Isotis said its products help the body regenerate bone without the risk of infection and minus the pain and risk of injury from harvesting bone from patients.
The company plans to hire at least 20 more manufacturing workers and another 15 to 20 office employees during the next year, Wolters said. Isotis has 115 employees.
Isotis’ operations are split between Irvine, Switzerland and the Netherlands.
Irvine is the company’s global headquarters, laboratory and manufacturing hub, Wolters said.
The company’s international sales and marketing base is in Lausanne, Switzerland. Isotis also has some office space in Bilthoven, Netherlands.
For more on this story, see Monday’s issue of the Business Journal.
